Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
The John P. Hussman Foundation
Susan Sartorius, RN
William Sharfman, M.D.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next post in Melanoma Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.